World's Best Scientists 2026 revealed!
Ronald M. Laxer

Ronald M. Laxer

D-Index & Metrics

Medicine

D-Index
86
Citations
25274
World Ranking
14208
National Ranking
589

Ronald M. Laxer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ronald M. Laxer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 396 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ronald M. Laxer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ronald M. Laxer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ronald M. Laxer is affiliated with the University of Toronto in Canada. Their research contributions span the field of Medicine with a strong emphasis on Surgery, Hematology, and Rheumatology, along with notable work in Molecular Biology and Speech and Hearing.

The scientist's research focuses on several key topics including autoimmune and inflammatory disorders, adolescent and pediatric healthcare, inflammasome and immune disorders, Kawasaki disease and coronary complications, osteomyelitis and bone disorders, infectious diseases and tuberculosis, as well as orthopedic infections and treatments.

Frequent co-authors in their work include Tala El Tal, Roberta Berard, Rae S. M. Yeung, Susanne M. Benseler, and Elena Pope, with multiple joint publications reflecting ongoing collaborative efforts.

They have published extensively in various respected venues, with a significant number of articles appearing in:

  • The Journal of Rheumatology
  • Arthritis & Rheumatology
  • Pediatric Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Lara D. Veeken

Representative recent papers include:

  • The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist, 2022, Annals of the Rheumatic Diseases
  • Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice, 2021, Nature Genetics
  • A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction, 2020, Nature Communications
  • The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial, 2020, Lara D. Veeken
  • American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1, 2020, Arthritis & Rheumatology

Best Publications

  • An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

    Ivona Aksentijevich;Seth L. Masters;Polly J. Ferguson;Paul Dancey

  • 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

    Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart

  • An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

    Scott W. Canna;Adriana Almeida de Jesus;Sushanth Gouni;Stephen R. Brooks

  • Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

    Qing Zhou;Hongying Wang;Daniella M. Schwartz;Monique Stoffels

  • Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.

    Anath C Lionel;Gregory Costain;Nasim Monfared;Susan Walker

  • Classification criteria for autoinflammatory recurrent fevers

    Marco Gattorno;Michael Hofer;Silvia Federici;Federica Vanoni

  • Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study

    F. Zulian;B. H. Athreya;R. Laxer;A. M. Nelson

  • Medical Treatment of Juvenile Idiopathic Arthritis

    Philip J. Hashkes;Ronald M. Laxer

  • Toward New Classification Criteria for Juvenile Idiopathic Arthritis : First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    Alberto Martini;Angelo Ravelli;Tadej Avcin;Michael W. Beresford

  • Localized scleroderma in childhood is not just a skin disease.

    Francesco Zulian;Cristina Vallongo;Patricia Woo;Ricardo Russo

  • 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications

    Sarah Ringold;Pamela F. Weiss;Timothy Beukelman;Esi Morgan DeWitt

  • CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.

    Jose Marcelino;John D. Carpten;Wafaa M. Suwairi;Orlando M. Gutierrez

  • Treating juvenile idiopathic arthritis to target: recommendations of an international task force

    Angelo Ravelli;Alessandro Consolaro;Gerd Horneff;Ronald M Laxer

  • Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up.

    Adam M. Huber;Pei-Yoong Lam;Catherine M. Duffy;Rae S.M. Yeung

  • Epidemiology of Juvenile Idiopathic Arthritis in a Multiethnic Cohort Ethnicity as a Risk Factor

    R. K. Saurenmann;J. B. Rose;P. Tyrrell;B. M. Feldman

  • Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study

    R. K. Saurenmann;A. V. Levin;B. M. Feldman;J. B. Rose

  • The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

    Jaime Guzman;Kiem Oen;Lori B Tucker;Adam M Huber

  • Tumour necrosis factor α inhibitors in the treatment of childhood uveitis

    R. K. Saurenmann;A. V. Levin;J. B. Rose;S. Parker

  • Methotrexate and corticosteroid therapy for pediatric localized scleroderma

    Yosef Uziel;Brian M. Feldman;Bernice R. Krafchik;Rae S.M. Yeung

  • The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis†‡

    Francesco Zulian;Patricia Woo;Balu H. Athreya;Ronald M. Laxer

Frequent Co-Authors

Earl D. Silverman
Earl D. Silverman University of Toronto
Brian M. Feldman
Brian M. Feldman University of Toronto
Daniel J. Lovell
Daniel J. Lovell Cincinnati Children's Hospital Medical Center
Seza Ozen
Seza Ozen Hacettepe University
Stuart E. Turvey
Stuart E. Turvey University of British Columbia
Marco Gattorno
Marco Gattorno Istituto Giannina Gaslini
Gideon Koren
Gideon Koren Brown University
Elie Haddad
Elie Haddad University of Montreal
Robert D. Inman
Robert D. Inman University of Toronto
Ivona Aksentijevich
Ivona Aksentijevich National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine goes beyond traditional medical school. Today, many find fulfilling and in-demand pathways through related healthcare programs available online. For those interested in the administrative side, earning a degree in healthcare administration can open doors to leadership roles without direct patient care.

If you’re looking for clinical opportunities, there are schools that offer nursing school that does not require teas test, making the entry process smoother for aspiring nurses. For registered nurses aiming to advance their careers, specialized bridge programs like rn to fnp bridge programs can help them become Family Nurse Practitioners through an accelerated route.

In the rapidly-growing field of medical billing, you may wonder, can you get financial aid for medical billing and coding? Many accredited programs offer options that make this career path more accessible.

Whether you’re drawn to clinical or administrative roles, these online degrees and career tracks provide flexible, accessible ways to enter or advance in the healthcare industry.

Best Scientists Citing Ronald M. Laxer

Trending Scientists

Recently Published Articles